2024
DOI: 10.1039/d3cs00786c
|View full text |Cite
|
Sign up to set email alerts
|

Protein-based bioactive coatings: from nanoarchitectonics to applications

Chengyu Fu,
Zhengge Wang,
Xingyu Zhou
et al.

Abstract: Assembly strategy and application direction of protein-based bioactive coatings.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 423 publications
(489 reference statements)
0
2
0
Order By: Relevance
“…In the case of IMDs, antimicrobial coatings present several benefits over traditional antibiotics (Figure 3). A key advantage is their localized action, where the coating shields the immediate surface of the implant from microbial attack without affecting distant tissues [19]. This localized protection can enhance patient comfort by eliminating the systemic side effects and complications often associated with antibiotic use [19].…”
Section: Infection On Implanted Medical Devicesmentioning
confidence: 99%
See 1 more Smart Citation
“…In the case of IMDs, antimicrobial coatings present several benefits over traditional antibiotics (Figure 3). A key advantage is their localized action, where the coating shields the immediate surface of the implant from microbial attack without affecting distant tissues [19]. This localized protection can enhance patient comfort by eliminating the systemic side effects and complications often associated with antibiotic use [19].…”
Section: Infection On Implanted Medical Devicesmentioning
confidence: 99%
“…A key advantage is their localized action, where the coating shields the immediate surface of the implant from microbial attack without affecting distant tissues [19]. This localized protection can enhance patient comfort by eliminating the systemic side effects and complications often associated with antibiotic use [19]. Moreover, employing antimicrobial coatings could lead to a decrease in the reliance on antibiotics, preserving them for critical therapeutic uses and potentially slowing down the development of antibiotic-resistant bacteria.…”
Section: Infection On Implanted Medical Devicesmentioning
confidence: 99%
“…7,17−23 Lysozyme, as a positively charged precursor protein with four disulfide bonds, was selected as a model protein for their potential to undergo disulfide-based restructuring and amyloid-type aggregation at interfaces. 3,4,24 Tris(2-carboxyethyl)phosphine (TCEP) used in this system can reduce disulfide bonds to dithiols, thus inducing the transformation of lysozyme from an oxidized folding state to a reduced folding state. 25 the previous SFG studies, lysozyme aggregated at the lipid monolayer interface in the low-pH environment 22,26 or only structured at the air/water, solid/water, or nanodroplet interfaces.…”
Section: ■ Introductionmentioning
confidence: 99%
“…As a powerful analytical technique suited for biointerface detection under nonvacuum conditions, sum frequency generation (SFG) vibrational spectroscopy has been widely employed to study interfacial proteins and lipid membranes, offering structural and dynamic information at the molecular level in situ in real time. The SFG process is intrinsically surface/interface-selective, as it is typically permitted at surfaces/interfaces where inversion symmetry is broken, rendering SFG highly sensitive to the biointerfaces associated with structural asymmetry. , Lysozyme, as a positively charged precursor protein with four disulfide bonds, was selected as a model protein for their potential to undergo disulfide-based restructuring and amyloid-type aggregation at interfaces. ,, Tris(2-carboxy­ethyl)phosphine (TCEP) used in this system can reduce disulfide bonds to dithiols, thus inducing the transformation of lysozyme from an oxidized folding state to a reduced folding state . As demonstrated in the previous SFG studies, lysozyme aggregated at the lipid monolayer interface in the low-pH environment , or only structured at the air/water, solid/water, or nanodroplet interfaces. However, lysozyme aggregation by the reductive pathway on lipid bilayer membranes, which is relatively efficient and physiological, , has not been fully appreciated and remains to be clarified, due to a lack of molecular-level understanding of the interfacial structures and the aggregation kinetics, along with the influence on transmembrane asymmetry.…”
Section: Introductionmentioning
confidence: 99%